Public Notice: New Mexico Medicaid Pharmacy and Therapeutics Public Meeting Announced
The New Mexico Medicaid Pharmacy & Therapeutics and Drug Utilization Review Committees will hold a regular quarterly meeting on Tuesday, Oct. 13, 8:00 a.m. virtually on Microsoft Teams. The public is welcome to attend.
The agenda will be posted at Preferred Drug List – New Mexico Health Care Authority or by emailing cynthia.gustafson@hca.nm.gov.
Any individual with a disability who needs a reader, amplifier, qualified signed language interpreter, or other form of auxiliary aid or service to attend or participate in the meeting must request that by Tuesday, Oct. 6 by emailing Cynthia Gustafson at cynthia.gustafson@hca.nm.gov.
Topic: Medicaid Pharmacy and Therapeutics Quarterly Meeting
Date: Tuesday, Oct. 13, 2026, 8:00 a.m. Mountain Time
Join by computer: https://teams.microsoft.com/meet/247269192493726?p=ny1cocB3aMNblwhEvp
Meeting ID: 247 269 192 493 726
Passcode: KR9Rb2Hf
Join by Telephone:
+1 505-312-4308,,648936219# United States, Albuquerque
(888) 506-1357,,648936219# United States (Toll-free)
Phone conference ID: 648 936 219#
###
About the New Mexico Health Care Authority
The New Mexico Health Care Authority connects New Mexicans to the care and support they need to live healthy, full lives. The agency administers Medicaid, the Supplemental Nutrition Assistance Program (SNAP), the Low-Income Home Energy Assistance Program (LIHEAP), cash assistance, child support services, and behavioral health care across the state. HCA also oversees the State Health Benefits program for state employees and manages the Health Care Affordability Fund to help make coverage more affordable for working families. The agency licenses health care facilities, investigates complaints, and ensures providers deliver safe, high-quality care. In addition, HCA supports individuals with intellectual and developmental disabilities through a variety of home and community-based programs that protect health, safety, and human rights.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
